nevirapine has been researched along with calanolide a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Han, C; Hu, J; Li, Y; Liu, G; Liu, L; Liu, Z; Lu, X; Ma, T; Wang, L; Xue, H; Zheng, P | 1 |
| Buckheit, R; Flavin, MT; Motakis, D; Parniak, MA; Quan, Y; Wainberg, MA; Xu, ZQ | 1 |
| Xie, L; Zhou, T | 1 |
1 review(s) available for nevirapine and calanolide a
| Article | Year |
|---|---|
[Progress in HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)].
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Coumarins; Cyclopropanes; Delavirdine; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Conformation; Molecular Structure; Nevirapine; Oxazines; Pyranocoumarins; Reverse Transcriptase Inhibitors | 2004 |
2 other study(ies) available for nevirapine and calanolide a
| Article | Year |
|---|---|
Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile.
Topics: Animals; Anti-HIV Agents; Biological Availability; Brain; Cell Line; Cell Survival; HIV Infections; HIV-1; Inhibitory Concentration 50; Mice; Models, Molecular; Molecular Structure; Mutation; Pyranocoumarins; Rats; Structure-Activity Relationship; Virus Replication | 2010 |
Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase.
Topics: Coumarins; Drug Resistance; HIV Reverse Transcriptase; HIV-1; Mutation; Nevirapine; Pyranocoumarins; Reverse Transcriptase Inhibitors; Virus Replication | 1999 |